|
PPID expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.111580E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.46450000000498E-05 |
| Normal-vs-Stage2 |
8.837200E-01 |
| Normal-vs-Stage3 |
6.108400E-01 |
| Normal-vs-Stage4 |
3.830200E-01 |
| Stage1-vs-Stage2 |
3.977800E-02 |
| Stage1-vs-Stage3 |
1.227630E-01 |
| Stage1-vs-Stage4 |
1.567540E-02 |
| Stage2-vs-Stage3 |
6.409000E-01 |
| Stage2-vs-Stage4 |
5.415600E-01 |
| Stage3-vs-Stage4 |
3.183400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.328000E-02 |
| Normal-vs-AfricanAmerican |
4.948100E-02 |
| Normal-vs-Asian |
8.837200E-01 |
| Caucasian-vs-AfricanAmerican |
5.708200E-01 |
| Caucasian-vs-Asian |
5.060800E-01 |
| AfricanAmerican-vs-Asian |
4.123200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.320470E-02 |
| Normal-vs-Female |
1.299250E-01 |
| Male-vs-Female |
7.296400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.336800E-03 |
| Normal-vs-Extreme_Weight |
3.624400E-02 |
| Normal-vs-Obese |
2.137800E-02 |
| Normal-vs-Extreme_Obese |
7.456600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.661800E-01 |
| Normal_Weight-vs-Obese |
8.914200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.011200E-01 |
| Extreme_Weight-vs-Obese |
6.637000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.616600E-01 |
| Obese-vs-Extreme_Obese |
4.434200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.923200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.809780E-01 |
| Normal-vs-Age(61-80Yrs) |
1.257960E-02 |
| Normal-vs-Age(81-100Yrs) |
1.366190E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.746400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.879400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.271810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.586400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.394200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.057000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.694400E-02 |
| Normal-VS-Type2 PRCC |
4.138500E-02 |
| Normal-VS-KIRP CIMP |
7.652600E-01 |
| Normal-VS-Unclassified PRCC |
3.749000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.616600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.468600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.952400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.827800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.390800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.007800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.496480E-03 |
| Normal-vs-N1 |
1.002020E-01 |
| Normal-vs-N2 |
2.722200E-01 |
| N0-vs-N1 |
3.458700E-03 |
| N0-vs-N2 |
8.045800E-01 |
| N1-vs-N2 |
1.394230E-01 |
|
|
